Dr Raluca Verona, Head, Oncology Precision Medicine Group at AbbVie, tells us how she is helping to advance the immuno-oncology field, and the power of real-world data, ADCs and T cell engagers for the next phase of cancer treatment.
Lead Editorial

Dr Raluca Verona, Head, Oncology Precision Medicine Group at AbbVie, tells us how she is helping to advance the immuno-oncology field, and the power of real-world data, ADCs and T cell engagers for the next phase of cancer treatment.